全文获取类型
收费全文 | 1305019篇 |
免费 | 97043篇 |
国内免费 | 4333篇 |
专业分类
耳鼻咽喉 | 18404篇 |
儿科学 | 42500篇 |
妇产科学 | 38129篇 |
基础医学 | 190560篇 |
口腔科学 | 35849篇 |
临床医学 | 112578篇 |
内科学 | 255535篇 |
皮肤病学 | 26738篇 |
神经病学 | 100768篇 |
特种医学 | 51009篇 |
外国民族医学 | 387篇 |
外科学 | 200304篇 |
综合类 | 31829篇 |
现状与发展 | 6篇 |
一般理论 | 302篇 |
预防医学 | 94229篇 |
眼科学 | 30202篇 |
药学 | 101196篇 |
27篇 | |
中国医学 | 4372篇 |
肿瘤学 | 71471篇 |
出版年
2018年 | 12896篇 |
2016年 | 11029篇 |
2015年 | 13165篇 |
2014年 | 17811篇 |
2013年 | 25826篇 |
2012年 | 35782篇 |
2011年 | 38406篇 |
2010年 | 22682篇 |
2009年 | 21178篇 |
2008年 | 36501篇 |
2007年 | 39452篇 |
2006年 | 40069篇 |
2005年 | 39561篇 |
2004年 | 37348篇 |
2003年 | 36204篇 |
2002年 | 35677篇 |
2001年 | 58707篇 |
2000年 | 60192篇 |
1999年 | 51399篇 |
1998年 | 14744篇 |
1997年 | 13301篇 |
1996年 | 13460篇 |
1995年 | 12706篇 |
1994年 | 12053篇 |
1993年 | 11067篇 |
1992年 | 41190篇 |
1991年 | 40553篇 |
1990年 | 40059篇 |
1989年 | 38837篇 |
1988年 | 36240篇 |
1987年 | 35434篇 |
1986年 | 33808篇 |
1985年 | 32190篇 |
1984年 | 23946篇 |
1983年 | 20841篇 |
1982年 | 12384篇 |
1981年 | 10944篇 |
1979年 | 22643篇 |
1978年 | 15877篇 |
1977年 | 13729篇 |
1976年 | 12970篇 |
1975年 | 14201篇 |
1974年 | 16682篇 |
1973年 | 16076篇 |
1972年 | 15318篇 |
1971年 | 14229篇 |
1970年 | 13214篇 |
1969年 | 12731篇 |
1968年 | 11978篇 |
1967年 | 10478篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
133.
Jünemann A. G. M. Rejdak R. Hohberger B. 《Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft》2016,113(11):897-905
Die Ophthalmologie - Die Filtrationsverfahren sind im Gegensatz zu allen anderen Glaukomoperationen mit einer biomikroskopisch sichtbaren Wundheilung assoziiert, sodass eine Vielzahl von... 相似文献
134.
Ana M. Gómez Angelica Imitola Diana Henao Maira García-Jaramillo Marga Giménez Clara Viñals Bruno Grassi Mariana Torres Isabella Zuluaga Oscar Mauricio Muñoz Martin Rondón Fabián León-Vargas Ignacio Conget 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):267-272
Background and aimsDespite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.Methodology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor ≥70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use.Results188 subjects were included (41 ± 13.8 years-old, 23 ± 12 years disease duration, A1c 7.2% ± 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1–10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19–1.61; p < 0.001), high glycemic variability defined as Coefficient of Variation (CV%) > 36% (IRR 2.09; 95%CI 1.79–2.45; p < 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66–0.90; p:0.001), and the use of bolus wizard >60% (IRR 0.74; 95%CI 0.58–0.95; p:0.017).ConclusionIn spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice. 相似文献
135.
136.
137.
目的 解析真实世界中乳腺恶性肿瘤患者的人群特征、诊断特征、中西医用药特征,为乳腺癌的临床防治提供参考。方法 采集2002年2月至2015年5月全国60家三级甲等医 院信息系统(Hospital Information System,HIS)中,出院诊断为“乳腺癌”的患者用药信息,采用SAS9.3统计软件,对人口学信息、诊断信息、医嘱用药信息等进行描述性分析。结果 39798例乳腺癌患者,平均年龄(50.93者,平均年龄)岁;多以门诊入院,入院病情以“一般”为主;合并疾病主要为高血压,骨肿瘤,联用西药以抑制肿瘤细胞增殖、治疗并发症、缓解放化疗不良反应为主;中医辨证以痰瘀互结证,气阴两虚证,肝气淤滞证,脾气亏虚证型最为常见,临床清热解毒剂、益气扶正剂,活血化瘀剂应用较多。结论 乳腺癌中西医结合治疗,联用药物广泛,临床治疗基本符合临床指南。 相似文献
138.
Adeline Tarantini Sylvie Huet Gérard Jarry Rachelle Lanceleur Martine Poul Ana Tavares Nádia Vital Henriqueta Louro Maria João Silva Valérie Fessard 《Environmental and molecular mutagenesis》2015,56(2):218-227
Synthetic amorphous silica (SAS) in its nanosized form is now used in food applications although the potential risks for human health have not been evaluated. In this study, genotoxicity and oxidative DNA damage of two pyrogenic (NM‐202 and 203) and two precipitated (NM‐200 and ‐201) nanosized SAS were investigated in vivo in rats following oral exposure. Male Sprague Dawley rats were exposed to 5, 10, or 20 mg/kg b.w./day for three days by gavage. DNA strand breaks and oxidative DNA damage were investigated in seven tissues (blood, bone marrow from femur, liver, spleen, kidney, duodenum, and colon) with the alkaline and the (Fpg)‐modified comet assays, respectively. Concomitantly, chromosomal damage was investigated in bone marrow and in colon with the micronucleus assay. Additionally, malondialdehyde (MDA), a lipid peroxidation marker, was measured in plasma. When required, a histopathological examination was also conducted. The results showed neither obvious DNA strand breaks nor oxidative damage with the comet assay, irrespective of the dose and the organ investigated. Similarly, no increases in chromosome damage in bone marrow or lipid peroxidation in plasma were detected. However, although the response was not dose‐dependent, a weak increase in the percentage of micronucleated cells was observed in the colon of rats treated with the two pyrogenic SAS at the lowest dose (5 mg/kg b.w./day). Additional data are required to confirm this result, considering in particular, the role of agglomeration/aggregation of SAS NMs in their uptake by intestinal cells. Environ. Mol. Mutagen. 56:218–227, 2015. © 2014 Wiley Periodicals, Inc. 相似文献
139.
140.